TA
ALNY icon

Teachers Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Teachers Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$11.9M Buy
127,013
+8,967
+8% +$750K 0.01% 907
2018
Q4 		$8.61M Buy
118,046
+6,593
+6% +$507K 0.01% 1005
2018
Q3 		$9.75M Buy
111,453
+151
+0.1% +$15.2K 0.01% 1086
2018
Q2 		$11M Buy
111,302
+3,812
+4% +$378K 0.01% 1041
2018
Q1 		$12.8M Buy
107,490
+4,709
+5% +$607K 0.02% 927
2017
Q4 		$13.1M Buy
102,781
+7,911
+8% +$994K 0.02% 935
2017
Q3 		$11.1M Buy
94,870
+10,191
+12% +$870K 0.02% 982
2017
Q2 		$6.75M Buy
84,679
+4,441
+6% +$284K 0.01% 1181
2017
Q1 		$4.11M Buy
80,238
+6,662
+9% +$308K 0.01% 1397
2016
Q4 		$2.75M Buy
73,576
+7,048
+11% +$295K ﹤0.01% 1600
2016
Q3 		$4.51M Buy
66,528
+3,114
+5% +$220K 0.01% 1258
2016
Q2 		$3.52M Buy
63,414
+3,897
+7% +$246K 0.01% 1340
2016
Q1 		$3.74M Sell
59,517
-52,120
-47% -$3.47M 0.01% 1256
2015
Q4 		$10.5M Sell
111,637
-52,991
-32% -$4.91M 0.02% 852
2015
Q3 		$13.2M Buy
164,628
+4,487
+3% +$499K 0.03% 717
2015
Q2 		$19.2M Buy
160,141
+62,948
+65% +$7.52M 0.04% 574
2015
Q1 		$10.1M Buy
97,193
+50,490
+108% +$5.12M 0.02% 884
2014
Q4 		$4.53M Sell
46,703
-50,612
-52% -$4.69M 0.01% 1180
2014
Q3 		$7.6M Sell
97,315
-676
-0.7% -$43.6K 0.02% 990
2014
Q2 		$6.19M Sell
97,991
-41,114
-30% -$2.44M 0.01% 1059
2014
Q1 		$9.34M Buy
139,105
+55,870
+67% +$4.33M 0.02% 839
2013
Q4 		$5.36M Buy
83,235
+2,671
+3% +$159K 0.01% 1061
2013
Q3 		$5.16M Buy
80,564
+3,732
+5% +$186K 0.01% 1020
2013
Q2 		$2.38M Buy
+76,832
New +$2.04M 0.01% 1325

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Teachers Advisors's ALNY Position: Q1 2019 in Review

Teachers Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 7.6% in Q1 2019, buying an estimated $750K and bringing the position to 127,013 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #907.

Teachers Advisors first reported a position in ALNY in Q2 2013 and has held it in 24 quarters since. The position peaked at $19.2M in Q2 2015. 290 funds tracked by Wall St. Rank hold ALNY as of Q1 2019.

  • Teachers Advisors held 127,013 shares of Alnylam Pharmaceuticals worth $11.9M as of Q1 2019.
  • Teachers Advisors bought 8,967 Alnylam Pharmaceuticals shares in Q1 2019, an estimated $750K.
  • Alnylam Pharmaceuticals made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #907 holding.
  • Teachers Advisors first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Alnylam Pharmaceuticals position peaked at $19.2M in Q2 2015.
  • 290 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.